Dysmenorrhea
Conditions
Brief summary
This study was planned to determine the effect of lavender inhalation on primary dysmenorrhea and its symptoms.
Detailed description
The research is a randomized controlled trial and an experimental research design will be used. The research will be carried out with two groups as experimental (lavender) and control (placebo) groups.
Interventions
Lavender inhalation will be administered to this group. Participants will be asked to drop three drops of lavender oil solution on a small piece of cotton on the 1st, 2nd, and 3rd days of their first menstrual bleeding after enrollment in the study, hold it 7-10 cm from their noses, and sniff for 5 minutes. Participants will be asked to apply this application immediately after the onset of dysmenorrhea pain on the first day of their menstruation and to continue regularly every 8 hours for the first three days of menstrual bleeding. Participants will be asked to apply this application in the same way in two consecutive menstrual cycles and the participants will be followed in this process.
OTHERPlacebo
Olive oil will be administered to the placebo group. The application will be similar to the experimental group.
Sponsors
Saglik Bilimleri Universitesi
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 30 Years
Healthy volunteers
Yes
Inclusion criteria
* Having primary dysmenorrhea (degrees II and III), * Single, * Who have never been pregnant before, * Having a regular menstrual cycle * Without any genital organ disorder (such as fibroids, fibroadenoma, endometriosis, metrorrhagia, ovarian cyst, pelvic inflammatory disease, chronic pelvic pain, other pelvic pathologies) * Not using contraceptive method, * Having a normal sense of smell * People who can smell odors and are not allergic to odors will be included in the study.
Exclusion criteria
* Married, * Having a disease that causes dysmenorrhea, * Regularly using a pharmacological and non-pharmacological method to relieve * Dysmenorrhea pain during the study, * Having a previous or unconcluded pregnancy, * Having a chronic disease (diabetes, endometriosis, uterine congenital anomalies, epilepsy, etc.), * Using drugs that affect the menstrual cycle or dysmenorrhea, * Persons who fill in the data collection form incompletely or not at all will not be included in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Dysmenorrhea Symptom Assessment Form | to assess post-intervention change; It is applied on the 1st, 2nd and 3rd days of the menstrual cycle during 2 menstrual cycles. | Form consists of questions about dysmenorrhea symptoms in the participants.As the score obtained from the form increases, the severity of the symptoms increases. |
| Numerical Pain Scale | to assess post-intervention change; It is applied on the 1st, 2nd and 3rd days of the menstrual cycle during 2 menstrual cycles. | It will be applied to evaluate the level of dysmenorrhea pain. Participants will be asked to rate their pain level from 0 to 10. As the score increases, the level of pain increases |
Countries
Turkey (Türkiye)
Contacts
Primary ContactGönül Kurt, Assist. Prof
Backup ContactGönül Kurt, Assist. Prof
Outcome results
None listed